Vertex Pharmaceuticals
VRTX
VRTX
481 hedge funds and large institutions have $20.7B invested in Vertex Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 204 increasing their positions, 162 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% less funds holding
Funds holding: 501 → 481 (-20)
23% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 61
Holders
481
Holding in Top 10
6
Calls
$81.8M
Puts
$81.3M
Top Buyers
| 1 | +$613M | |
| 2 | +$166M | |
| 3 | +$61.3M | |
| 4 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$50.6M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$45.4M |
Top Sellers
| 1 | -$399M | |
| 2 | -$152M | |
| 3 | -$86M | |
| 4 |
Goldman Sachs
New York
|
-$66.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$66.7M |